JIPOAd
ESID
  • Users Online: 753
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2019| July-September  | Volume 2 | Issue 3  
    Online since August 22, 2019

 
 
  Archives   Previous Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
EXPERT OPINION
Immunotherapy use in patients with HIV and non-small-cell lung cancer: Current data
Katherine A Scilla, Alessandro Russo, Christian Rolfo
July-September 2019, 2(3):55-58
DOI:10.4103/JIPO.JIPO_13_19  
  607 37 -
CASE REPORT
Eosinophilic fasciitis in a patient treated by atezolizumab for metastatic triple-negative breast cancer
Yacine Wissam, Laila Belcaid, Ruth Wittoek, Vanessa Smith, Amber Vanhaecke, Sofie De Schepper, Lennart Jans, Daphné t'Kint de Roodenbeke, Andrea Gombos, Sandrine Aspeslagh
July-September 2019, 2(3):101-105
DOI:10.4103/JIPO.JIPO_8_19  
  570 24 -
REVIEW ARTICLES
Neuromuscular weakness syndromes from immune checkpoint inhibitors: A case series and literature review
Ahmad Daher, Carlos Kamiya Matsuoka, Monica Elena Loghin, Marta Penas-Prado, Sudhakar Tummala
July-September 2019, 2(3):93-100
DOI:10.4103/JIPO.JIPO_3_19  
  538 34 -
ORIGINAL RESEARCH
Safety of immune checkpoint blockade in patients with cancer and preexisting autoimmune diseases and/or chronic inflammatory disorders
Mohsin Shah, Mazen N Jizzini, Imad E Majzoub, Aiham Qdaisat, Cielito C Reyes-Gibby, Sai-Ching Yeung
July-September 2019, 2(3):59-64
DOI:10.4103/JIPO.JIPO_11_19  
  489 48 -
Rheumatic and musculoskeletal adverse events with immune checkpoint inhibitors: Data from the United States Food and Drug Administration adverse event reporting system
Xerxes N Pundole, Mayur Sarangdhar, Maria E Suarez-Almazor
July-September 2019, 2(3):65-73
DOI:10.4103/JIPO.JIPO_12_19  
  426 39 -
REVIEW ARTICLES
Kaposi's sarcoma in the immunosuppressed
Nisha A Reddy, Steven R Mays, Omar Pacha
July-September 2019, 2(3):74-78
DOI:10.4103/JIPO.JIPO_10_19  
  442 18 -
EDITORIAL
Cancer immunotherapy for the immunosuppressed: Dissecting the conundrum of safety and efficacy
Joud Hajjar
July-September 2019, 2(3):53-54
DOI:10.4103/JIPO.JIPO_15_19  
  321 48 -
REVIEW ARTICLES
Common cutaneous neoplasms in patients with immunodeficiency: A case series
Suhair Al Salihi, Haider A Mejbel, Victor G Prieto, Phyu P Aung
July-September 2019, 2(3):79-84
DOI:10.4103/JIPO.JIPO_9_19  
  283 15 -
CONFERENCE PROCEEDINGS
Meeting Proceedings of the First Immuno-Oncology Society of India Conference (I-OSICON-2019), Mumbai, India
Jyoti Bajpai, Ram Abhinav Kannan, Hemant Malhotra, Vivek Radhakrishnan, Rakesh Jalali, Gaurav Narula, Amit Awasthi, Girdhari Lal, Rahul Purvar, Kumar Prabhash, Senthil Rajappa, Atul Sharma, Moni Kuriakose, Vikram Matthews, Reena Nair, Smruti Koppikar, Shubhda V Chiplunkar, Shripad Banavali
July-September 2019, 2(3):106-125
DOI:10.4103/2666-2345.265156  
  223 25 -
REVIEW ARTICLES
Review: The impact of HIV infection on cancer treatment with immunotherapy
Bruno Palma Granwehr
July-September 2019, 2(3):85-92
DOI:10.4103/JIPO.JIPO_14_19  
  167 10 -